Hereditary genes
Pro Research Analysisby 
Searched over 200M research papers for "hereditary genes"
Understanding Hereditary Genes: Insights from Recent Research
Hereditary Anemias: Genetic Testing and Diagnosis
Hereditary anemias are a diverse group of disorders characterized by significant clinical and genetic variability, which complicates accurate diagnosis. Traditionally, diagnosis involved family and personal history analysis, followed by biochemical and morphological evaluations, and finally genetic testing. However, the advent of next-generation sequencing (NGS) has revolutionized this process. NGS, including custom-designed targeting panels and whole-exome sequencing, is now a preferred method for differential diagnosis, enabling the identification of new causative genes and polygenic conditions that modify disease severity . Whole-genome sequencing further aids in identifying non-coding mutations and disruptions in chromatin structures, which are crucial for understanding gene expression errors .
Hereditary Prostate Cancer: Genetic Susceptibility and Clinical Implications
Hereditary prostate cancer is significantly influenced by family history, with dominantly inherited susceptibility genes accounting for 5% to 10% of all cases and up to 40% of early-onset cases. Despite the identification of several chromosome loci, no major susceptibility gene has been cloned yet. Environmental factors and common gene variants also play a role in familial prostate cancer risk. Clinically, hereditary prostate cancer is diagnosed earlier than sporadic cases, leading to higher mortality rates. Screening remains the primary strategy to reduce mortality by diagnosing the disease at a curable stage .
Multigene Panel Testing for Hereditary Cancer
Multigene panel testing (MGPT) has become a common approach for identifying hereditary cancer predispositions. A study involving 165,000 high-risk patients revealed significant genetic heterogeneity in cancer predisposition genes. Pathogenic variant frequencies varied across cancer types, with the highest in ovarian cancer and the lowest in melanoma. The study highlighted the need to revise testing criteria for BRCA1/2 and Lynch syndrome to include additional actionable genes and to relax criteria for associated cancers to improve patient identification .
Phenome-Wide Association Studies in Hereditary Cancer
A phenome-wide association study using data from three large cohorts identified new disease associations with hereditary cancer genes. For instance, CHEK2 was associated with leukemia and plasma cell neoplasms, while ATM was linked to gastric and pancreatic cancers. These findings underscore the potential of using electronic health records (EHRs) in genomic medicine to facilitate early detection and better management of cancers .
Genetic Basis of Hereditary Amyotrophic Lateral Sclerosis (ALS)
Hereditary ALS is caused by mutations in 12 genes, with SOD1, FUS, and TARDBP being the most common. These genes account for 25% to 35% of familial ALS cases. The inheritance patterns include autosomal dominant, autosomal recessive, and X-linked. Hereditary ALS typically presents with a lower mean age of onset compared to sporadic ALS, but clinical features overlap significantly between the two forms. Genetic counseling and risk assessment depend on identifying the specific gene defect and its penetrance within the family .
In Vivo Gene Therapy for Hereditary Diseases
Gene therapy using Adeno-associated Virus (AAV) vectors has shown promise in treating hereditary diseases. AAV vectors do not integrate into the patient genome and have low immunogenicity, making them suitable for gene delivery. Approved treatments include therapies for neuromuscular disorders, central nervous system diseases, ocular disorders, hemophilia, and lysosomal storage disorders. Ongoing clinical trials continue to explore the potential of AAV-mediated gene therapy for various hereditary conditions .
Hereditary Pancreatic Cancer: Molecular Features and Management
Hereditary pancreatic cancer is linked to germline mutations in several genes, including BRCA1, BRCA2, ATM, and others. These mutations account for about 10% of pancreatic cancer cases. Targeted therapies, such as PARP inhibitors for BRCA mutations and immune checkpoint inhibitors for mismatch repair deficiencies, are currently available. Surveillance procedures for high-risk individuals and transgenic murine models are essential for understanding carcinogenesis and improving management strategies .
Genetic Insights into Hereditary Colon Cancer
Hereditary colon cancer, including familial adenomatous polyposis (FAP) and Lynch syndrome, has provided significant insights into human cancer genetics. Germline mutations in key genes have elucidated critical molecular pathways involved in cancer development and have led to advancements in chemoprevention, molecular diagnostics, and therapy. Understanding these genetic mechanisms is crucial for developing targeted treatments and improving patient outcomes .
Hereditary Breast Cancer: Syndromes and Molecular Testing
Approximately 20% of hereditary breast cancers are due to pathogenic variants in BRCA1 and BRCA2 genes. Other susceptibility genes include ATM, CHEK2, PALB2, and those associated with specific syndromes like Li-Fraumeni and Cowden syndrome. Polygenic risk also contributes to breast cancer susceptibility. Molecular testing and understanding genotype-phenotype correlations are vital for personalized treatment and management of hereditary breast cancer .
Conclusion
The study of hereditary genes has significantly advanced our understanding of various genetic disorders and cancers. Next-generation sequencing and multigene panel testing have revolutionized diagnosis and treatment, enabling the identification of new genetic associations and improving patient management. Continued research and technological advancements hold promise for further breakthroughs in the field of hereditary genetics.
Sources and full results
Most relevant research papers on this topic